| Literature DB >> 34898514 |
Steven L Simon1, André Bouville2, Harold L Beck3, Lynn R Anspaugh4, Kathleen M Thiessen5, F Owen Hoffman5, Sergey Shinkarev6.
Abstract
ABSTRACT: In recent years, the prospects that a nuclear device might be detonated due to a regional or global political conflict, by violation of present nuclear weapons test ban agreements, or due to an act of terrorism, has increased. Thus, the need exists for a well conceptualized, well described, and internally consistent methodology for dose estimation that takes full advantage of the experience gained over the last 70 y in both measurement technology and dose assessment methodology. Here, the models, rationale, and data needed for a detailed state-of-the-art dose assessment for exposure to radioactive fallout from nuclear detonations discussed in five companion papers are summarized. These five papers present methods and data for estimating radionuclide deposition of fallout radionuclides, internal and external dose from the deposited fallout, and discussion of the uncertainties in the assessed doses. In addition, this paper includes a brief discussion of secondary issues related to assessments of radiation dose from fallout. The intention of this work is to provide a usable and consistent methodology for both prospective and retrospective assessments of exposure from radioactive fallout from a nuclear detonation.Entities:
Mesh:
Substances:
Year: 2022 PMID: 34898514 PMCID: PMC8677604 DOI: 10.1097/HP.0000000000001501
Source DB: PubMed Journal: Health Phys ISSN: 0017-9078 Impact factor: 1.316
Thirty-four radionuclides recommended for consideration in future assessments of dose from radioactive fallout; indented radionuclides are progeny of preceding (parent) nuclides. The doses from activities of progeny nuclides that arise in the body following intakes of the parents are accounted for by the parent dose coefficients; the doses from activities of progeny nuclides deposited on the ground are to be calculated separately.
| Radionuclide | Half-life | Organs/tissues in adults receiving greatest dose via ingestion | Organs/tissues in adults receiving greatest dose via inhalation |
|---|---|---|---|
| 89Sr | 50.6 d | Bone surfaces, Colon, active marrow | Bone surfaces, Colon, active marrow, lung |
| 90Sr | 28.9 a | Bone surfaces, Colon, active marrow | Colon, bone surfaces, active marrow, lung |
| 90Y | 64.1 h | Stomach wall, colon | Stomach wall, colon, lung |
| 91Sr | 9.65 h | Colon | Colon, lung |
| 91Y | 58.5 d | Colon | Colon, lung |
| 92Sr | 2.66 h | Stomach wall, colon | Stomach wall, colon, lung |
| 92Y | 3.54 h | Colon | Colon, lung |
| 93Y | 10.2 h | Stomach wall, colon | Stomach wall, colon, lung |
| 97Zr | 16.7 h | Colon | Colon, lung |
| 97Nb | 72.1 min | Stomach wall, colon | Stomach wall, colon, lung |
| 99Mo | 66.0 h | Colon | Colon, lung |
| 99mTc | 6.0 h | Stomach wall, thyroid | Lung, colon |
| 103Ru | 39.2 d | Bladder wall, stomach wall, colon, ovaries, active marrow, uterus | Colon, lung |
| 103mRh | 56.1 min | Stomach wall, colon | Lung, stomach wall |
| 105Ru | 4.4 h | Colon, stomach wall | Lung, colon |
| 105Rh | 35.4 h | Colon | Lung, colon |
| 106Ru | 372 d | Stomach wall, colon | Colon, lung |
| 132Te | 3.20 d | Bone surfaces, colon, thyroid, ovaries | Bone surfaces, colon, thyroid |
| 132I | 2.30 h | Thyroid | Thyroid |
| 131I | 8.03 d | Thyroid | Thyroid |
| 133I | 20.8 h | Thyroid | Thyroid |
| 135I | 6.58 h | Thyroid | Thyroid |
| 137Cs | 30.1 a | All | All |
| 140Ba | 12.8 d | Bone surfaces, colon, ovaries | Colon, lung |
| 140La | 1.68 d | Colon | Colon, lung |
| 141La | 3.92 h | Stomach wall, colon | Stomach wall, colon, lung |
| 142La | 91.1 min | Stomach wall, colon | Stomach wall, colon, lung |
| 143Ce | 33.0 h | Colon | Colon, lung |
| 143Pr | 13.6 d | Colon | Colon, lung |
| 144Ce | 285 d | Colon | Colon, lung |
| 144Pr | 17.3 min | Stomach wall | Stomach wall, lung |
| 145Pr | 5.98 h | Stomach wall, colon | Stomach wall, colon, lung |
| 239Np | 2.36 d | Colon | Colon, lung |
| 239Pu | 24,100 a | Colon | Lung |